These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38869647)

  • 1. Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.
    Balayssac D; Kerckhove N; Selvy M; Pereira B; Gonneau C; Pétorin C; Vimal-Baguet A; Melnikov S; Kullab S; Hebbar M; Bouché O; Slimano F; Bourgeois V; Lebrun-Ly V; Thuillier F; Mazard T; Tavan D; Benmammar KE; Monange B; Ramdani M; Péré-Vergé D; Huet-Penz F; Bedjaoui A; Genty F; Leyronnas C; Pezet D; Martin V
    Support Care Cancer; 2024 Jun; 32(7):427. PubMed ID: 38869647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
    Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
    Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
    Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
    Selvy M; Kerckhove N; Pereira B; Barreau F; Nguyen D; Busserolles J; Giraudet F; Cabrespine A; Chaleteix C; Soubrier M; Bay JO; Lemal R; Balayssac D
    Front Pharmacol; 2021; 12():637593. PubMed ID: 33967771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
    Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
    Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
    Orszaghova Z; Galikova D; Lesko P; Obertova J; Rejlekova K; Sycova-Mila Z; Palacka P; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M; Chovanec M
    Clin Genitourin Cancer; 2024 Jun; 22(3):102067. PubMed ID: 38555680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study.
    Hsu HT; Wu LM; Lin PC; Juan CH; Huang YY; Chou PL; Chen JL
    Medicine (Baltimore); 2020 Feb; 99(6):e19029. PubMed ID: 32028414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors.
    Teng C; ; Blinman PL; Vardy JL
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1308-1315. PubMed ID: 36509075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
    Kerckhove N; Selvy M; Lambert C; Gonneau C; Feydel G; Pétorin C; Vimal-Baguet A; Melnikov S; Kullab S; Hebbar M; Bouché O; Slimano F; Bourgeois V; Lebrun-Ly V; Thuillier F; Mazard T; Tavan D; Benmammar KE; Monange B; Ramdani M; Péré-Vergé D; Huet-Penz F; Bedjaoui A; Genty F; Leyronnas C; Busserolles J; Trévis S; Pinon V; Pezet D; Balayssac D
    Front Pharmacol; 2021; 12():744085. PubMed ID: 34803689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.
    Teng C; Cohen J; Egger S; Blinman PL; Vardy JL
    Support Care Cancer; 2022 Jan; 30(1):33-47. PubMed ID: 34410459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
    Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
    J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population.
    Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O
    Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trial.
    Lemanska A; Harkin A; Iveson T; Kelly C; Saunders M; Faithfull S
    ESMO Open; 2023 Dec; 8(6):102063. PubMed ID: 37988949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study.
    Tabata A; Kanai M; Horimatsu T; Tsuboyama T; Matsushima K; Kato T
    Support Care Cancer; 2018 Jul; 26(7):2397-2405. PubMed ID: 29423680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
    Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
    J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
    Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
    Soveri LM; Lamminmäki A; Hänninen UA; Karhunen M; Bono P; Osterlund P
    Acta Oncol; 2019 Apr; 58(4):398-406. PubMed ID: 30638100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
    Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
    J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.